Key facts

Active Substance
  • Telmisartan
  • Amlodipine besilate
Therapeutic area
Cardiovascular diseases
Decision number
P/0264/2015
PIP number
EMEA-001845-PIP01-15
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries

Krka, d.d. Novo mesto

Croatia
Tel. +385 9931 10291
Fax +385 1631 2153
E-mail: helen.lukin@krka.biz

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date

Decision

P/0264/2015: EMA decision of 30 October 2015 on the granting of a product specific waiver for telmisartan / amlodipine (besilate) (EMEA-001845-PIP01-15)

How useful do you find this page?